If you’re a small defense technology company right now, chances are you’re running on caffeine, adrenaline, and a calendar full of proposal deadlines. The U.S. military and its warfare research centers are releasing RFPs at a dizzying pace. Companies with the agility to mobilize seasoned capture teams can ratchet up their chances for wins.
As
Two co-founders, one CEO and one EVP. One owned more than the other, got paid better, had bigger bonuses. How did this happen?
“We were always very clear with each other about who would have what role,” the EVP once told me. I observed that almost everything between them was consultative, even to a fault.
Economics in getting a compound approved and commercialized are evolving. Drug companies have reduced budgets that historically funded vast R&D teams. Innovators are chasing tight investment dollars. The two camps are increasingly collaborating.
There is a self-selection factor rewarding start-ups — they can’t attract funding or licensing deals unless they’ve protected their intellectual property, showed
Migration is already underway, but some of the world’s largest organizations are still reluctant. They handle proprietary data and a staggering volume of transactions. They want to marshal information and deliver nuanced results. But a lack of appreciation for the Cloud’s promise, together with questions surrounding security and cost, make many CTOs and COOs cling
Photo credit: MassChallenge
It’s another season at the world’s largest accelerator, MassChallenge, where hundreds of start-up businesses across the globe are polishing their pitches in hopes of getting mentored and landing that critical investor audience. Sitting for several years on judging panels, I’ve honed my tips about an alluring approach.
Photo credit: MassChallenge
I
Cyber liability may have been an exotic notion as recently as a couple of years ago. When I practiced law in Israel, we spent a lot of time thinking about how the country’s privacy laws matched up to those of Europe and the U.S. But today, even after notorious breaches, some organizations are still wringing
Israel is a garden of inventiveness and Israelis have a strong tradition of contributing to technology and life sciences. Breathing the innovation when I lived there, I was privileged to test PrimeSense’s 3D camera, help bring Notal Vision’s tool to gauge macular degeneration to the United States, deliver a turn-key VoIP network in Nigeria and Zambia on behalf of VocalTec, license ecommerce and security software to dozens of Fortune 100 companies, watch knee surgery with miraculous tissue-repairing Regentis hydrogel, play with a gear box created from an Objet (now Stratasys) 3D printer, and negotiate sponsored research, patent licenses and clinical trials on behalf of emerging pharmaceutical companies.
Figuring out what gives rise to the “start-up nation” character, with wildly disproportionate foreign direct investment and numbers of translated books, cited academics, filed patents, Nasdaq companies, successful exits, and tuneful children’s songs, is a pervasive new-age question. Many answers have been floated, including its world-class research institutions, the very first technology transfer offices for commercialization of academic R&D, raw skills honed in one of the best-trained and most-sophisticated militaries, a culture of questioning, and a flood of ex-Soviet engineering talent over three decades. Naturally one can’t discount that there are real issues to be addressed too. Israelis have done it — from discerning security risks through synthesis of big data to making the desert bloom with fruit, vegetables, fish, and minerals.
Continue Reading Ingenuity in Israel’s Water